Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1780415
PUBLISHER: GlobalData | PRODUCT CODE: 1780415
North America Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests
PUBLISHED:
PAGES: 92 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "North America Reproductive Health Diagnostics Market Outlook to 2033" is a comprehensive databook report, covering key market data on the North America Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening and Reproductive Hormones and Proteins Tests
The North America Reproductive Health Diagnostics Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Reproductive Health Diagnostics Market.
- Global corporate-level profiles of key companies operating within the North America Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
North America Reproductive Health Diagnostics is segmented as follows -
- Prenatal Screening
- Reproductive Hormones and Proteins Tests
Reasons to Buy
The North America Reproductive Health Diagnostics Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME20434CRDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Reproductive Health Diagnostics Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Reproductive Health Diagnostics Market, North America
- 3.1 Reproductive Health Diagnostics Market, North America, Revenue ($m), 2018-2033
- 3.2 Reproductive Health Diagnostics Market, North America, Revenue ($m), 2018-2033
- 3.3 Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033
- 3.4 Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033
- 3.5 Reproductive Health Diagnostics Market, North America, Company Share by Revenue ($m), 2024
4 Reproductive Health Diagnostics Market, Mexico
- 4.1 Reproductive Health Diagnostics Market, Mexico, Revenue ($m), 2018-2033
- 4.1.1 Prenatal Screening Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 4.1.2 Reproductive Hormones and Proteins Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
- 4.2 Reproductive Health Diagnostics Market, Mexico, Volume (Units), 2018-2033
- 4.2.1 Prenatal Screening Market, Mexico, Volume (Units), by Segment, 2018-2033
- 4.2.2 Reproductive Hormones and Proteins Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
- 4.3 Reproductive Health Diagnostics Market, Mexico, Average Price ($), 2018-2033
- 4.4 Reproductive Health Diagnostics Market, Mexico, Company Share by Revenue ($m), 2024
5 Reproductive Health Diagnostics Market, Canada
- 5.1 Reproductive Health Diagnostics Market, Canada, Revenue ($m), 2018-2033
- 5.1.1 Prenatal Screening Market, Canada, Revenue ($m), by Segment, 2018-2033
- 5.1.2 Reproductive Hormones and Proteins Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
- 5.2 Reproductive Health Diagnostics Market, Canada, Volume (Units), 2018-2033
- 5.2.1 Prenatal Screening Market, Canada, Volume (Units), by Segment, 2018-2033
- 5.2.2 Reproductive Hormones and Proteins Tests Market, Canada, Volume (Units), by Segment, 2018-2033
- 5.3 Reproductive Health Diagnostics Market, Canada, Average Price ($), 2018-2033
- 5.4 Reproductive Health Diagnostics Market, Canada, Company Share by Revenue ($m), 2024
6 Reproductive Health Diagnostics Market, United States
- 6.1 Reproductive Health Diagnostics Market, United States, Revenue ($m), 2018-2033
- 6.1.1 Prenatal Screening Market, United States, Revenue ($m), by Segment, 2018-2033
- 6.1.2 Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), by Segment, 2018-2033
- 6.2 Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033
- 6.2.1 Prenatal Screening Market, United States, Volume (Units), by Segment, 2018-2033
- 6.2.2 Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), by Segment, 2018-2033
- 6.3 Reproductive Health Diagnostics Market, United States, Average Price ($), 2018-2033
- 6.4 Reproductive Health Diagnostics Market, United States, Company Share by Revenue ($m), 2024
7 Overview of Key Companies in North America Reproductive Health Diagnostics Market
- 7.1 Illumina Inc
- 7.1.1 Company Overview
- 7.2 Quidelortho Corp
- 7.2.1 Company Overview
- 7.3 Danaher Corp
- 7.3.1 Company Overview
- 7.4 F. Hoffmann-La Roche Ltd
- 7.4.1 Company Overview
- 7.5 Siemens AG
- 7.5.1 Company Overview
- 7.6 Abbott Laboratories
- 7.6.1 Company Overview
- 7.7 BGI Genomics Co Ltd
- 7.7.1 Company Overview
8 Reproductive Health Diagnostics Market Pipeline Products
9 Recent Developments
- 9.1 Strategy And Business Planning
- 9.1.1 Apr 22, 2025: Advantia Health Teams Up With Mirvie to Bring Predictive and Preventive Care to Maternal Health
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Coverage
- 10.1.2 Secondary Research
- 10.1.3 Primary Research
- 10.1.4 Market Modeling and Forecasting
- 10.1.5 Company Share Analysis
- 10.1.6 Benchmarking
- 10.2 GlobalData Consulting
- 10.3 Contact Us
- 10.4 Disclaimer
Product Code: GDME20434CRDB
List of Table
List of Tables
- Table 1: Reproductive Health Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
- Table 2: Reproductive Health Diagnostics Market, North America, Revenue ($m), USD Constant, 2018-2033
- Table 3: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033
- Table 4: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033
- Table 5: Reproductive Health Diagnostics Market, North America, Company Share by Revenue ($m), 2024
- Table 6: Reproductive Health Diagnostics Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Table 7: Prenatal Screening Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Table 8: Reproductive Hormones and Proteins Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Table 9: Reproductive Health Diagnostics Market, Mexico, Volume (Units), 2018-2033
- Table 10: Prenatal Screening Market, Mexico, Volume (Units), 2018-2033
- Table 11: Reproductive Hormones and Proteins Tests Market, Mexico, Volume (Units), 2018-2033
- Table 12: Reproductive Health Diagnostics Market, Mexico, Average Price ($), 2018-2033
- Table 13: Reproductive Health Diagnostics Market, Mexico, Company Share by Revenue ($m), 2024
- Table 14: Reproductive Health Diagnostics Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Table 15: Prenatal Screening Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Table 16: Reproductive Hormones and Proteins Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Table 17: Reproductive Health Diagnostics Market, Canada, Volume (Units), 2018-2033
- Table 18: Prenatal Screening Market, Canada, Volume (Units), 2018-2033
- Table 19: Reproductive Hormones and Proteins Tests Market, Canada, Volume (Units), 2018-2033
- Table 20: Reproductive Health Diagnostics Market, Canada, Average Price ($), 2018-2033
- Table 21: Reproductive Health Diagnostics Market, Canada, Company Share by Revenue ($m), 2024
- Table 22: Reproductive Health Diagnostics Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 23: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 24: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 25: Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033
- Table 26: Prenatal Screening Market, United States, Volume (Units), 2018-2033
- Table 27: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2018-2033
- Table 28: Reproductive Health Diagnostics Market, United States, Average Price ($), 2018-2033
- Table 29: Reproductive Health Diagnostics Market, United States, Company Share by Revenue ($m), 2024
- Table 30: Reproductive Health Diagnostics Market Pipeline Products
- Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figure
List of Figures
- Figure 1: Reproductive Health Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Reproductive Health Diagnostics Market, North America, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033
- Figure 4: Reproductive Health Diagnostics Market, North America, Volume (Units), 2018-2033
- Figure 5: Reproductive Health Diagnostics Market, North America, Company Share (%), 2024
- Figure 6: Reproductive Health Diagnostics Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Figure 7: Prenatal Screening Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Figure 8: Reproductive Hormones and Proteins Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
- Figure 9: Reproductive Health Diagnostics Market, Mexico, Volume (Units), 2018-2033
- Figure 10: Prenatal Screening Market, Mexico, Volume (Units), 2018-2033
- Figure 11: Reproductive Hormones and Proteins Tests Market, Mexico, Volume (Units), 2018-2033
- Figure 12: Reproductive Health Diagnostics Market, Mexico, Company Share (%), 2024
- Figure 13: Reproductive Health Diagnostics Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Figure 14: Prenatal Screening Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Figure 15: Reproductive Hormones and Proteins Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
- Figure 16: Reproductive Health Diagnostics Market, Canada, Volume (Units), 2018-2033
- Figure 17: Prenatal Screening Market, Canada, Volume (Units), 2018-2033
- Figure 18: Reproductive Hormones and Proteins Tests Market, Canada, Volume (Units), 2018-2033
- Figure 19: Reproductive Health Diagnostics Market, Canada, Company Share (%), 2024
- Figure 20: Reproductive Health Diagnostics Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 21: Prenatal Screening Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 22: Reproductive Hormones and Proteins Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 23: Reproductive Health Diagnostics Market, United States, Volume (Units), 2018-2033
- Figure 24: Prenatal Screening Market, United States, Volume (Units), 2018-2033
- Figure 25: Reproductive Hormones and Proteins Tests Market, United States, Volume (Units), 2018-2033
- Figure 26: Reproductive Health Diagnostics Market, United States, Company Share (%), 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.